Roche Holding AG (RHHBF)
RHHBF Stock Price Chart
Explore Roche Holding AG interactive price chart. Choose custom timeframes to analyze RHHBF price movements and trends.
RHHBF Company Profile
Discover essential business fundamentals and corporate details for Roche Holding AG (RHHBF) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Drug Manufacturers - General
IPO Date
3 Aug 2012
Employees
103.25K
Website
https://www.roche.comCEO
Thomas Schinecker
Description
Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Switzerland, Germany, the United States, Austria, Netherlands, the United Kingdom, France, Belgium, and internationally. The company offers pharmaceutical products for treating oncology, neuroscience, infectious, immunology, cardiovascular and metabolism, ophthalmology, and respiratory, as well as anemia, cancer, dermatology, hemophilia, inflammatory and autoimmune, neurological, and transplantation. It also offers in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and other diseases. In addition, the company supplies diagnostic instruments and reagents. It has a research collaboration agreement with Synlogic, Inc. for the discovery of a novel synthetic biotic for the treatment of inflammatory bowel disease (IBD). The company was founded in 1896 and is headquartered in Basel, Switzerland.
RHHBF Financial Timeline
Browse a chronological timeline of Roche Holding AG corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 28 Jan 2026
Earnings released on 24 Jul 2025
EPS came in at $13.97 surpassing the estimated $13.18 by +5.99%, while revenue for the quarter reached $40.14B , beating expectations by +161.94%.
Earnings released on 30 Jan 2025
EPS came in at $2.77 falling short of the estimated $9.25 by -70.05%, while revenue for the quarter reached $34.84B , beating expectations by +2.78%.
Dividend declared on 30 Jan 2025
A dividend of $11.01 per share was announced, adjusted to $10.97. The dividend was paid on 31 Mar 2025.
Earnings released on 23 Oct 2024
EPS came in at $8.71 falling short of the estimated $10.42 by -16.41%, while revenue for the quarter reached $34.33B , beating expectations by +4.22%.
Earnings released on 26 Apr 2024
EPS came in at $6.34 falling short of the estimated $10.07 by -37.04%, while revenue for the quarter reached $33.82B , missing expectations by -2.69%.
Dividend declared on 1 Feb 2024
A dividend of $10.87 per share was announced, adjusted to $10.93. The dividend was paid on 18 Mar 2024.
Earnings released on 29 Nov 2023
EPS came in at $9.90 falling short of the estimated $11.62 by -14.80%, while revenue for the quarter reached $33.20B , missing expectations by -1.87%.
Earnings released on 2 Feb 2023
EPS came in at $5.26 falling short of the estimated $9.49 by -44.57%, while revenue for the quarter reached $33.50B , beating expectations by +0.09%.
Dividend declared on 2 Feb 2023
A dividend of $10.22 per share was announced, adjusted to $10.18. The dividend was paid on 20 Mar 2023.
Earnings released on 21 Jul 2022
EPS came in at $10.99 falling short of the estimated $11.53 by -4.68%, while revenue for the quarter reached $33.71B , beating expectations by +0.31%.
Earnings released on 3 Feb 2022
EPS came in at $7.81 falling short of the estimated $10.68 by -26.87%, while revenue for the quarter reached $35.09B , beating expectations by +0.21%.
Dividend declared on 3 Feb 2022
A dividend of $9.95 per share was announced, adjusted to $9.89. The dividend was paid on 21 Mar 2022.
Earnings released on 21 Oct 2021
EPS came in at $9.80 falling short of the estimated $10.96 by -10.58%, while revenue for the quarter reached $33.25B , beating expectations by +1.84%.
Earnings released on 21 Apr 2021
EPS came in at $8.14 falling short of the estimated $9.96 by -18.27%, while revenue for the quarter reached $32.85B , missing expectations by -3.37%.
Dividend declared on 4 Feb 2021
A dividend of $9.80 per share was announced, adjusted to $9.87. The dividend was paid on 22 Mar 2021.
Earnings released on 15 Oct 2020
EPS came in at $9.87 falling short of the estimated $11.18 by -11.72%, while revenue for the quarter reached $30.97B , missing expectations by -4.01%.
RHHBF Stock Performance
Access detailed RHHBF performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.